Chengcang Charles Wu
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$11.3MFederal grants as PI16 awards
1Patents grantedLatest Jul 2, 2019
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
16 awards · $11.3M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jun 20, 2024 | NIH | SBIR Phase II Rapid dissection of the biosynthesis of antiMRSA antibiotics produced in co-culture by extremophilic fungi through the development of Fungal Artificial Chromosomes | $960K | INTACT GENOMICS INC |
| Jul 19, 2023 | NIH | SBIR Phase I A Platform to Identify Antifungal Compounds with Novel Action Mechanisms | $300K | INTACT GENOMICS INC |
| Jun 30, 2023 | NIH | SBIR Phase II Rapid dissection of the biosynthesis of antiMRSA antibiotics produced in co-culture by extremophilic fungi through the development of Fungal Artificial Chromosomes | $983K | INTACT GENOMICS INC |
| Jul 1, 2022 | NIH | SBIR Phase II Rapid dissection of the biosynthesis of antiMRSA antibiotics produced in co-culture by extremophilic fungi through the development of Fungal Artificial Chromosomes | $1000K | INTACT GENOMICS INC |
| Jan 13, 2022 | NIH | SBIR Phase II Rapid discovery of thousands of intact biosynthetic gene pathways for bioactive natural product compounds from un-sequenced filamentous fungi using a novel FAC-NGS tool | $1.0M | INTACT GENOMICS INC |
| Feb 9, 2021 | NIH | SBIR Phase II Rapid discovery of thousands of intact biosynthetic gene pathways for bioactive natural product compounds from un-sequenced filamentous fungi using a novel FAC-NGS tool | $1.0M | INTACT GENOMICS INC |
| Jan 30, 2020 | NIH | SBIR Phase II Rapid discovery of thousands of intact biosynthetic gene pathways for bioactive natural product compounds from un-sequenced filamentous fungi using a novel FAC-NGS tool | $1.0M | INTACT GENOMICS INC |
| May 23, 2019 | NIH | SBIR Phase II A robust heterologous expression system of intact fungal secondary metabolite gene clusters for natural product discovery in Aspergillus nidulans | $746K | INTACT GENOMICS INC |
| Jan 15, 2019 | NIH | SBIR Phase II Rapid discovery of thousands of intact biosynthetic gene pathways for bioactive natural product compounds from un-sequenced filamentous fungi using a novel FAC-NGS tool | $300K | INTACT GENOMICS INC |
| Jul 5, 2018 | NIH | SBIR Phase I Rapid dissection of the biosynthesis of antiMRSA antibiotics produced in co-culture by extremophilic fungi through the development of Fungal Artificial Chromosomes | $229K | INTACT GENOMICS INC |
| May 31, 2018 | NIH | SBIR Phase II A robust heterologous expression system of intact fungal secondary metabolite gene clusters for natural product discovery in Aspergillus nidulans | $750K | INTACT GENOMICS INC |
| Jun 16, 2017 | NIH | SBIR Phase II Activate Silent and Cryptic Intact Fungal SM Gene Clusters through FACs for Novel Antibiotics Discovery | $873K | INTACT GENOMICS INC |
| Jul 13, 2016 | NIH | SBIR Phase II Activate Silent and Cryptic Intact Fungal SM Gene Clusters through FACs for Novel Antibiotics Discovery | $901K | INTACT GENOMICS INC |
| Mar 8, 2016 | NIH | SBIR Phase I A robust heterologous expression system of intact fungal secondary metabolite gene clusters for natural product discovery in Aspergillus nidulans | $225K | INTACT GENOMICS INC |
| Apr 10, 2015 | NIH | SBIR Phase II Expanding small molecule functional metagenomics through shuttle BAC expression i | $861K | INTACT GENOMICS INC |
| Jan 14, 2015 | NIH | SBIR Phase I Activate Silent and Cryptic Intact Fungal SM Gene Clusters through FACs for Novel Antibiotics Discovery | $211K | INTACT GENOMICS INC |
2 patents as inventor
- US 10337019INTACT GENOMICS INCJul 2, 2019
- US INTACT GENOMICS INC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#49
Awards as PI#37
Patents#155
Companies
- INTACT GENOMICS INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.